Piedmont Investment Advisors LLC grew its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 86,070 shares of the medical research company’s stock after buying an additional 2,663 shares during the period. Piedmont Investment Advisors LLC’s holdings in Thermo Fisher Scientific were worth $16,284,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in TMO. Covington Capital Management boosted its holdings in shares of Thermo Fisher Scientific by 0.9% during the second quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock worth $374,000 after purchasing an additional 20 shares during the last quarter. Investment Centers of America Inc. boosted its holdings in shares of Thermo Fisher Scientific by 1.6% during the second quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock worth $230,000 after purchasing an additional 21 shares during the last quarter. Fort Washington Investment Advisors Inc. OH boosted its holdings in shares of Thermo Fisher Scientific by 0.4% during the second quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock worth $1,090,000 after purchasing an additional 23 shares during the last quarter. Bienville Capital Management LLC boosted its holdings in shares of Thermo Fisher Scientific by 1.6% during the second quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock worth $295,000 after purchasing an additional 27 shares during the last quarter. Finally, Savant Capital LLC boosted its holdings in shares of Thermo Fisher Scientific by 1.0% during the second quarter. Savant Capital LLC now owns 2,793 shares of the medical research company’s stock worth $487,000 after purchasing an additional 29 shares during the last quarter. 86.22% of the stock is owned by institutional investors.
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the transaction, the chief executive officer now owns 302,577 shares in the company, valued at $58,016,113.98. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.49% of the company’s stock.
Several equities research analysts have recently issued reports on the company. Zacks Investment Research cut Thermo Fisher Scientific from a “hold” rating to a “sell” rating in a report on Thursday. BTIG Research assumed coverage on Thermo Fisher Scientific in a report on Friday, January 5th. They issued a “buy” rating and a $230.00 target price on the stock. Evercore ISI assumed coverage on Thermo Fisher Scientific in a report on Wednesday, January 3rd. They issued an “outperform” rating and a $220.00 target price on the stock. Leerink Swann reiterated an “outperform” rating and issued a $200.00 target price (down previously from $216.00) on shares of Thermo Fisher Scientific in a report on Monday, December 4th. Finally, Deutsche Bank set a $226.00 target price on Thermo Fisher Scientific and gave the company a “buy” rating in a report on Thursday, October 26th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and fifteen have given a buy rating to the company. Thermo Fisher Scientific presently has an average rating of “Buy” and an average target price of $212.21.
Shares of Thermo Fisher Scientific Inc. (NYSE TMO) traded up $1.51 on Friday, hitting $210.17. The company’s stock had a trading volume of 1,486,494 shares, compared to its average volume of 1,680,000. The firm has a market capitalization of $83,840.00, a PE ratio of 35.68, a PEG ratio of 1.70 and a beta of 1.06. Thermo Fisher Scientific Inc. has a 12 month low of $140.00 and a 12 month high of $211.54. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping the Zacks’ consensus estimate of $2.24 by $0.07. The company had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The firm’s quarterly revenue was up 13.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.03 earnings per share. analysts predict that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.19%.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/01/13/piedmont-investment-advisors-llc-has-16-28-million-stake-in-thermo-fisher-scientific-inc-tmo.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.